Utilization of HER2 genetic testing in a multi-institutional observational study.
about
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer.Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancerFully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation studyMedical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.
P2860
Utilization of HER2 genetic testing in a multi-institutional observational study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Utilization of HER2 genetic testing in a multi-institutional observational study.
@ast
Utilization of HER2 genetic testing in a multi-institutional observational study.
@en
type
label
Utilization of HER2 genetic testing in a multi-institutional observational study.
@ast
Utilization of HER2 genetic testing in a multi-institutional observational study.
@en
prefLabel
Utilization of HER2 genetic testing in a multi-institutional observational study.
@ast
Utilization of HER2 genetic testing in a multi-institutional observational study.
@en
P2093
P2860
P1476
Utilization of HER2 genetic testing in a multi-institutional observational study.
@en
P2093
Adedayo A Onitilo
Alanna K Rahm
Erin J Aiello Bowles
Jennifer A Webster
Katrina A B Goddard
Larissa Nekhlyudov
Laurel A Habel
Sharon Hensley Alford
P2860
P304
P577
2012-11-01T00:00:00Z